Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 127 citations
Electronic publication date
May 1, 1998

View on Pubmed.gov 9563494 View on doi.org

Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis.

Search for publications in this journal Cancer Res - 58(8):1750-3

Abstract

Recent studies indicate that nonsteroidal anti-inflammatory drugs have a chemopreventive effect against colorectal neoplasia. Nonsteroidal anti-inflammatory drugs inhibit cyclooxygenases, principal enzymes that mediate the formation of prostanoids. To determine whether prostanoids are involved in the pathogenesis of colorectal adenomas, we compared the levels of five major stable metabolic products of the cyclooxygenase pathway in the normal-appearing mucosa and in adenomas of patients with familial adenomatosis polyposis. Of 12 patients tested, 6 had elevated levels of at least one prostanoid in the adenomas. More importantly, the relative levels of three prostanoids [prostaglandin (PG)D2, PGE2, and 6-keto-PGF1alpha] were elevated in adenomas compared to normal-appearing mucosa from the same patients, and the resulting ratios were correlated with the size of the adenoma. These results suggest a role for prostanoids in progression of colorectal polyposis in familial adenomatosis polyposis patients.

References

No references provided.

Cited by 127 citations (total)

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.

Electronic publication date March 4, 2000

Search for publications in this journal Prostaglandins Other Lipid Mediat

V W Yang [...] F M Giardiello et al.

Recent studies indicate that sulindac, a nonsteroidal anti-inflammatory drug (NSAID), lowers mucosal prostanoid levels and regresses colorectal adenomas in patients...

Journal Article

Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2.

Electronic publication date January 14, 2009

Search for publications in this journal BMC Cancer

Ivonne Löffler [...] Ignacio Rubio et al.

BACKGROUND

Prostaglandin E2 (PGE2), a product of the cyclooxygenase (COX) reaction, stimulates the growth of colonic epithelial cells. It is inferred...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Substances